In IL-13Rα2-targeted therapy, blocking IL-13Rα2 with monoclonal antibodies inhibited hepatic metastasis of colorectal cancer cells in animals through suppression of the Src-PI3K/AKT pathway [45]. This evidence concerns the gene AKT1 and colorectal cancer.